OCA
Octagon Capital Advisors’s Dyne Therapeutics DYN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-668,000
| Closed | -$15.7M | – | 36 |
|
|
2024
Q4 | $15.7M | Buy |
668,000
+405,274
| +154% | +$9.55M | 2.59% | 15 |
|
|
2024
Q3 | $9.44M | Sell |
262,726
-918,072
| -78% | -$33M | 1.47% | 17 |
|
|
2024
Q2 | $41.7M | Sell |
1,180,798
-62,147
| -5% | -$2.19M | 6.55% | 5 |
|
|
2024
Q1 | $35.3M | Buy |
1,242,945
+450,000
| +57% | +$12.8M | 4.23% | 5 |
|
|
2023
Q4 | $10.5M | Buy |
792,945
+100,000
| +14% | +$1.33M | 1.69% | 15 |
|
|
2023
Q3 | $6.21M | Hold |
692,945
| – | – | 0.95% | 20 |
|
|
2023
Q2 | $7.8M | Hold |
692,945
| – | – | 1.08% | 17 |
|
|
2023
Q1 | $7.98M | Buy |
+692,945
| New | +$7.98M | 1.15% | 18 |
|
|
2022
Q2 | – | Sell |
-525,284
| Closed | -$5.06M | – | 22 |
|
|
2022
Q1 | $5.06M | Sell |
525,284
-58,365
| -10% | -$563K | 1.09% | 19 |
|
|
2021
Q4 | $6.94M | Hold |
583,649
| – | – | 1.35% | 17 |
|
|
2021
Q3 | $9.48M | Hold |
583,649
| – | – | 2.33% | 14 |
|
|
2021
Q2 | $12.3M | Hold |
583,649
| – | – | 2.54% | 12 |
|
|
2021
Q1 | $9.06M | Buy |
583,649
+102,111
| +21% | +$1.59M | 3.41% | 12 |
|
|
2020
Q4 | $10.1M | Buy |
+481,538
| New | +$10.1M | 3.51% | 13 |
|